Trials / Completed
CompletedNCT00380003
Efficacy Study of EVT 201 to Treat Insomnia
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Crossover Study to Assess the Efficacy of Two Doses of EVT 201 in the Treatment of Primary Insomnia in Adult Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (planned)
- Sponsor
- Evotec Neurosciences GmbH · Industry
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EVT 201 |
Timeline
- Start date
- 2006-09-01
- Completion
- 2007-04-01
- First posted
- 2006-09-25
- Last updated
- 2008-01-30
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00380003. Inclusion in this directory is not an endorsement.